NLS PHARMACEUTICS LTD (NLSP) Stock Price, Quote, News and Overview
NASDAQ:NLSP - Nasdaq - CH1384053976 - Common Stock - Currency: USD
NLSP Quote, Performance and Key Statistics
NLS PHARMACEUTICS LTD
NASDAQ:NLSP (1/27/2025, 8:16:28 PM)
1.81
+0.03 (+1.69%)
The current stock price of NLSP is 1.81 USD. In the past month the price decreased by -4.41%. In the past year, price decreased by -90.77%.
NLSP Latest News, Press Releases and Analysis
Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS
/PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of...
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market Share
/PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of...
What's Going On With NLS Pharmaceuticals Stock Monday?
NLS Pharmaceuticals stock is moving higher on Monday after the company announced it filed a F-4 registration statement with the SEC ahead of a proposed merger.
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger
/PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of...
NLS Pharmaceutics CEO Issues Letter to Shareholders
NLSP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.47 | 767.21B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.27 | 388.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.3 | 368.10B | ||
| MRK | MERCK & CO. INC. | 16.46 | 247.75B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.39 | 217.32B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 206.74B | ||
| PFE | PFIZER INC | 10.41 | 152.22B | ||
| SNY | SANOFI-ADR | 12.7 | 133.73B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.79 | 122.91B | ||
| ZTS | ZOETIS INC | 30.04 | 78.07B | ||
| GSK | GSK PLC-SPON ADR | 8.57 | 72.43B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.25 | 42.32B |
Related stock screener links
About NLSP
Company Profile
NLS Pharmaceutics AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Zurich, Zuerich and currently employs 3 full-time employees. The company went IPO on 2021-01-29. NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Company Info
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370 CH
CEO: Alexander Zwyer
Employees: 7
Company Website: https://nlspharma.com/
Investor Relations: http://nlspharma.com/investors/sec-filings/
Phone: 41445122150
NLSP FAQ
What is the stock price of NLSP?
The current stock price of NLSP is 1.81 USD.
What is the symbol for NLS PHARMACEUTICS LTD stock?
The exchange symbol of NLS PHARMACEUTICS LTD is NLSP and it is listed on the Nasdaq exchange.
On which exchange is NLSP stock listed?
NLSP stock is listed on the Nasdaq exchange.
Is NLSP a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NLSP, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NLSP.
Does NLSP stock pay dividends?
NLSP does not pay a dividend.
When does NLSP stock report earnings?
NLSP will report earnings on 2022-12-13, before the market open.
What is the Price/Earnings (PE) ratio of NLSP?
NLSP does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.72).
What is the Short Interest ratio of NLSP stock?
The outstanding short interest for NLSP is 29.78% of its float.
NLSP Technical Analysis
NLSP Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NLSP. NLSP may be in some trouble as it scores bad on both profitability and health.
NLSP Financial Highlights
Over the last trailing twelve months NLSP reported a non-GAAP Earnings per Share(EPS) of -6.72. The EPS decreased by 19.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -552.61% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NLSP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to NLSP. The Buy consensus is the average rating of analysts ratings from 6 analysts.